| Hdfc Pharma And Healthcare Fund Datagrid | ||||||
|---|---|---|---|---|---|---|
| Category | Pharma Fund | |||||
| BMSMONEY | Rank | N/A | ||||
| Rating | N/A | |||||
| Growth Option 16-06-2026 | ||||||
| NAV | ₹19.51(R) | -0.09% | ₹20.15(D) | -0.08% | ||
| Returns | 1Y | 3Y | 5Y | 7Y | 10Y | |
| Lumpsum | Regular | 16.31% | -% | -% | -% | -% |
| Direct | 17.67% | -% | -% | -% | -% | |
| Nifty Pharma TRI | 10.52% | 23.11% | 12.03% | 18.07% | 9.18% | |
| SIP (XIRR) | Regular | 22.69% | -% | -% | -% | -% |
| Direct | 24.07% | -% | -% | -% | -% | |
| Ratio | Sharpe Ratio | Sortino Ratio | Sterling Ratio | Jensen's Alpha | Treynor Ratio | |
| Risk | STD. Dev | VaR 1Y95% | Max DD | Beta | Semi Devi. | |
| Fund AUM | As on: 30/12/2025 | 1976 Cr | ||||
NAV Date: 16-06-2026
| Scheme Name | NAV | Rupee Change | Percent Change |
|---|---|---|---|
| HDFC Pharma and Healthcare Fund - IDCW Option | 19.51 |
-0.0200
|
-0.0900%
|
| HDFC Pharma and Healthcare Fund - Growth Option | 19.51 |
-0.0200
|
-0.0900%
|
| HDFC Pharma and Healthcare Fund - IDCW Option - Direct Plan | 20.15 |
-0.0200
|
-0.0800%
|
| HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan | 20.15 |
-0.0200
|
-0.0800%
|
Review Date: 16-06-2026
Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.
Data Source: www.amfiindia.com
| KPIs* | Fund | Nifty Pharma TRI | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
|---|---|---|---|---|---|---|
| 1M Return % | 1.23 | -2.34 |
0.26
|
-1.91 | 1.89 | 5 | 16 | Good |
| 3M Return % | 14.94 | 7.26 |
11.81
|
7.49 | 15.23 | 2 | 16 | Very Good |
| 6M Return % | 13.49 | 7.29 |
8.55
|
3.80 | 13.87 | 2 | 16 | Very Good |
| 1Y Return % | 16.31 | 10.52 |
8.69
|
3.86 | 16.31 | 1 | 15 | Very Good |
| 1Y SIP Return % | 22.69 |
12.95
|
-5.34 | 22.77 | 2 | 15 | Very Good |
| KPIs* | Fund | Nifty Pharma TRI | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
|---|---|---|---|---|---|---|
| 1M Return % | 1.32 | -2.34 | 0.36 | -1.84 | 1.99 | 5 | 16 | Good |
| 3M Return % | 15.26 | 7.26 | 12.19 | 7.73 | 15.70 | 2 | 16 | Very Good |
| 6M Return % | 14.14 | 7.29 | 9.29 | 4.54 | 14.80 | 2 | 16 | Very Good |
| 1Y Return % | 17.67 | 10.52 | 10.16 | 4.79 | 17.67 | 1 | 15 | Very Good |
| 1Y SIP Return % | 24.07 | 14.44 | -4.04 | 24.72 | 2 | 15 | Very Good |
Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.
| Date | Hdfc Pharma And Healthcare Fund NAV Regular Growth | Hdfc Pharma And Healthcare Fund NAV Direct Growth |
|---|---|---|
| 16-06-2026 | 19.512 | 20.152 |
| 15-06-2026 | 19.529 | 20.169 |
| 12-06-2026 | 19.67 | 20.313 |
| 11-06-2026 | 19.539 | 20.177 |
| 10-06-2026 | 19.504 | 20.14 |
| 09-06-2026 | 19.634 | 20.274 |
| 08-06-2026 | 19.519 | 20.154 |
| 05-06-2026 | 19.507 | 20.141 |
| 04-06-2026 | 19.377 | 20.006 |
| 03-06-2026 | 19.226 | 19.85 |
| 02-06-2026 | 19.159 | 19.779 |
| 01-06-2026 | 19.155 | 19.775 |
| 29-05-2026 | 19.305 | 19.928 |
| 27-05-2026 | 19.386 | 20.01 |
| 26-05-2026 | 19.395 | 20.019 |
| 25-05-2026 | 19.312 | 19.933 |
| 22-05-2026 | 19.29 | 19.908 |
| 21-05-2026 | 19.509 | 20.134 |
| 20-05-2026 | 19.468 | 20.091 |
| 19-05-2026 | 19.413 | 20.034 |
| 18-05-2026 | 19.274 | 19.89 |
| Fund Launch Date: 04/Oct/2023 |
| Fund Category: Pharma Fund |
| Investment Objective: To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. |
| Fund Description: An open-ended equity scheme investing in Pharma and healthcare companies |
| Fund Benchmark: BSE Healthcare Index |
Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.